Singapore

BMI View: The increasingly ageing population and the corresponding increase in the burden of diseases will create growth opportunities for pharmaceutical firms and healthcare providers... 2013-02-08

BMI View: The establishment of a biologics production facility in Singapore by Novartis highlights the country's strength in biotechnology development. We maintain that while Singapore... 2012-11-01

BMI Core View: Uptake of generic drugs following patent expiry will become swifter. This trend will reduce costs for governments, out-of-pocket payers and insurance companies, which... 2012-08-07

BMI View: The biomedical sector will remain a key economic engine for Singapore. It will continue to attract foreign commercial sector interest due to the country's relatively stable... 2012-07-17

BMI View: The Solomon Islands will continue to rely on aid to improve healthcare access. The country has a high burden of non-communicable and communicable diseases, which makes efficient... 2012-07-06

BMI View: Singapore's pharmaceutical trade contracted in 2011, while growth in medical devices trade slowed sharply. We attribute this downturn to the general weakness in the global... 2012-06-11

BMI View: The high prevalence of myopia (shortsightedness) in Asia will continue to boost demands for eyewear, contact lenses and corrective surgical procedures. While there are many... 2012-06-08